acyclovir
Generic: acyclovir
Labeler: bryant ranch prepackDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
bryant ranch prepack
Dosage Form
TABLET
Routes
Active Ingredients
acyclovir 800 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71335-1222
Product ID
71335-1222_af2a25d9-8333-4f9e-8ff8-36562f8d654f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210401
Listing Expiration
2026-12-31
Marketing Start
2018-05-04
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
713351222
Hyphenated Format
71335-1222
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA210401 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 800 mg/1
Packaging
- 500 TABLET in 1 BOTTLE (71335-1222-0)
- 25 TABLET in 1 BOTTLE (71335-1222-1)
- 35 TABLET in 1 BOTTLE (71335-1222-2)
- 30 TABLET in 1 BOTTLE (71335-1222-3)
- 60 TABLET in 1 BOTTLE (71335-1222-4)
- 50 TABLET in 1 BOTTLE (71335-1222-5)
- 10 TABLET in 1 BOTTLE (71335-1222-6)
- 40 TABLET in 1 BOTTLE (71335-1222-7)
- 21 TABLET in 1 BOTTLE (71335-1222-8)
- 90 TABLET in 1 BOTTLE (71335-1222-9)
Packages (10)
71335-1222-0
500 TABLET in 1 BOTTLE (71335-1222-0)
71335-1222-1
25 TABLET in 1 BOTTLE (71335-1222-1)
71335-1222-2
35 TABLET in 1 BOTTLE (71335-1222-2)
71335-1222-3
30 TABLET in 1 BOTTLE (71335-1222-3)
71335-1222-4
60 TABLET in 1 BOTTLE (71335-1222-4)
71335-1222-5
50 TABLET in 1 BOTTLE (71335-1222-5)
71335-1222-6
10 TABLET in 1 BOTTLE (71335-1222-6)
71335-1222-7
40 TABLET in 1 BOTTLE (71335-1222-7)
71335-1222-8
21 TABLET in 1 BOTTLE (71335-1222-8)
71335-1222-9
90 TABLET in 1 BOTTLE (71335-1222-9)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "af2a25d9-8333-4f9e-8ff8-36562f8d654f", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197313"], "spl_set_id": ["8d171c3d-de39-4f82-bacb-3e8d71b16540"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (71335-1222-0)", "package_ndc": "71335-1222-0", "marketing_start_date": "20250130"}, {"sample": false, "description": "25 TABLET in 1 BOTTLE (71335-1222-1)", "package_ndc": "71335-1222-1", "marketing_start_date": "20190607"}, {"sample": false, "description": "35 TABLET in 1 BOTTLE (71335-1222-2)", "package_ndc": "71335-1222-2", "marketing_start_date": "20190603"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-1222-3)", "package_ndc": "71335-1222-3", "marketing_start_date": "20190513"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (71335-1222-4)", "package_ndc": "71335-1222-4", "marketing_start_date": "20250130"}, {"sample": false, "description": "50 TABLET in 1 BOTTLE (71335-1222-5)", "package_ndc": "71335-1222-5", "marketing_start_date": "20190506"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (71335-1222-6)", "package_ndc": "71335-1222-6", "marketing_start_date": "20250130"}, {"sample": false, "description": "40 TABLET in 1 BOTTLE (71335-1222-7)", "package_ndc": "71335-1222-7", "marketing_start_date": "20190523"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (71335-1222-8)", "package_ndc": "71335-1222-8", "marketing_start_date": "20250130"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71335-1222-9)", "package_ndc": "71335-1222-9", "marketing_start_date": "20250130"}], "brand_name": "Acyclovir", "product_id": "71335-1222_af2a25d9-8333-4f9e-8ff8-36562f8d654f", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "71335-1222", "generic_name": "Acyclovir", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA210401", "marketing_category": "ANDA", "marketing_start_date": "20180504", "listing_expiration_date": "20261231"}